Sally Choe, outgoing director of the FDA's Office of Generic Drugs
FDA's top generic drug leader puts in her two weeks as GDUFA III looms
The FDA is about to lose another top leader with the departure of Sally Choe, director of the FDA’s Office of Generic Drugs, on Oct …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
